What is the main business of Jasminum?

The main business activity of Jasminum focuses on dispensing chemist in specialised stores.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on May 7, 2009.

Where is the headquarters located?

The headquarters is located at: ul. Franciszkańska 14, 00-214 Warszawa.

Who is on the management board?

The management board consists of: Aneta Dic (Member of the Management Board) and Marek Jarosław Jąkalski (Member of the Management Board).

What is the share capital?

The share capital of the company is PLN 25,000 (approx. $6,753).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What was the revenue?

In 2024, the company generated total revenue of $948,272, representing a decrease of 3.3% compared to 2023.

No, in 2024 the company was not profitable, reporting a net loss of $57,518. For comparison, in 2023 the loss was $20,735, meaning the company increased its loss by 163.5%.

Which cost dominates operating expenses?

The largest operating cost category falls under other operating costs. This category amounted to $742,259 in 2024, representing 74% of all operating expenses.

Jasminumsp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2009-05-07

Share capital

25,000.00 PLN

Registered address

ul. Franciszkańska 14/102, 00-214 Warszawa, Poland

Electronic delivery address

AE:PL-96903-71228-JCRUC-32

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 89 days late).

2025filed
202419/06/2025
202313/06/2024
202207/07/2023
202112/10/2022
202029/09/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 927.44kMedianUSD 1.92mAverageUSD 5.20m

Net profit

This companyUSD -41.38kMedianUSD 20.66kAverageUSD 86.62k

Operating costs

This companyUSD 960.93kMedianUSD 1.88mAverageUSD 5.04m

Assets

This companyUSD 89.89kMedianUSD 544.32kAverageUSD 1.76m

Industry

Authorized Representatives

Aneta Dic – Management Board Member

Marek Jarosław Jąkalski – Management Board Member

Manner of representation

Each member of the management board independently.

Ownership

Owner	Shares	Share value	Stake
Aneta Dicage 45	75	$2,025.93	30%
Forest sp. z o.o.	175	$4,727.17	70%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2009-06-01.

mBank
41 1140 2004 0000 3602 8045 5140

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $12,502.

Grant date	Purpose	Gross amount	Granting body
Jul 2, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$3,091$3,091	Prezes Zakładu Ubezpieczeń Społecznych
Jul 2, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$2,764$2,764	Prezes Zakładu Ubezpieczeń Społecznych
Jul 2, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$2,708$2,708	Prezes Zakładu Ubezpieczeń Społecznych

Competitors

Name	Revenue	Website
Cosmedicasp. z o.o.	$49,355,260.75	cosmedica.pl
DR ZdrowieS.A.	$40,415,498.47	drzdrowie.pl
MagmaxS.A.	$4,200,912.15	magmaxsa.pl
Novopharm - Millersp. j.	$2,839,228.36	apteka.zyj-zdrowo.com
MaglowS.A.	$1,356,219.12	maglow.pl
Farmacja Im. O. Klimuszkisp. z o.o.	$1,289,548.20	zyj-zdrowo.com
Nukloversp. z o.o.	$227,479.26	nuklover.com
Massmedsp. z o.o.	$49,747.70	mojoapps.co
DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w WarszawieS.A.	$2,740.83	kwendasa.pl
Femaherbsp. z o.o.	$655.76	femaherb.com